ID   OPSD_HUMAN              Reviewed;         348 AA.
AC   P08100; Q16414; Q2M249;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   13-FEB-2019, entry version 211.
DE   RecName: Full=Rhodopsin;
DE   AltName: Full=Opsin-2;
GN   Name=RHO; Synonyms=OPN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6589631; DOI=10.1073/pnas.81.15.4851;
RA   Nathans J., Hogness D.S.;
RT   "Isolation and nucleotide sequence of the gene encoding human
RT   rhodopsin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4851-4855(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S.,
RA   Tsutsumi S., Aburatani H., Asai K., Akiyama Y.;
RT   "Genome-wide diskovery and analysis of human seven transmembrane helix
RT   receptor genes.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-120.
RX   PubMed=8566799; DOI=10.1016/0378-1119(95)00688-5;
RA   Bennett J., Beller B., Sun D., Kariko K.;
RT   "Sequence analysis of the 5.34-kb 5' flanking region of the human
RT   rhodopsin-encoding gene.";
RL   Gene 167:317-320(1995).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25664179; DOI=10.1186/s13630-015-0013-1;
RA   Chuang J.Z., Hsu Y.C., Sung C.H.;
RT   "Ultrastructural visualization of trans-ciliary rhodopsin cargoes in
RT   mammalian rods.";
RL   Cilia 4:4-4(2015).
RN   [7]
RP   INTERACTION WITH GRK1 AND SAG, FUNCTION, AND MUTAGENESIS OF GLU-113
RP   AND MET-257.
RX   PubMed=28524165; DOI=10.1038/cr.2017.72;
RA   He Y., Gao X., Goswami D., Hou L., Pal K., Yin Y., Zhao G.,
RA   Ernst O.P., Griffin P., Melcher K., Xu H.E.;
RT   "Molecular assembly of rhodopsin with G protein-coupled receptor
RT   kinases.";
RL   Cell Res. 27:728-747(2017).
RN   [8] {ECO:0000244|PDB:4ZWJ}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF MUTANT GLN-113 AND TYR-257
RP   IN COMPLEX WITH SAG, INTERACTION WITH SAG AND GNAT1, FUNCTION,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF GLU-113 AND MET-257, TOPOLOGY,
RP   AND DISULFIDE BONDS.
RX   PubMed=26200343; DOI=10.1038/nature14656;
RA   Kang Y., Zhou X.E., Gao X., He Y., Liu W., Ishchenko A., Barty A.,
RA   White T.A., Yefanov O., Han G.W., Xu Q., de Waal P.W., Ke J.,
RA   Tan M.H., Zhang C., Moeller A., West G.M., Pascal B.D., Van Eps N.,
RA   Caro L.N., Vishnivetskiy S.A., Lee R.J., Suino-Powell K.M., Gu X.,
RA   Pal K., Ma J., Zhi X., Boutet S., Williams G.J., Messerschmidt M.,
RA   Gati C., Zatsepin N.A., Wang D., James D., Basu S., Roy-Chowdhury S.,
RA   Conrad C.E., Coe J., Liu H., Lisova S., Kupitz C., Grotjohann I.,
RA   Fromme R., Jiang Y., Tan M., Yang H., Li J., Wang M., Zheng Z., Li D.,
RA   Howe N., Zhao Y., Standfuss J., Diederichs K., Dong Y., Potter C.S.,
RA   Carragher B., Caffrey M., Jiang H., Chapman H.N., Spence J.C.,
RA   Fromme P., Weierstall U., Ernst O.P., Katritch V., Gurevich V.V.,
RA   Griffin P.R., Hubbell W.L., Stevens R.C., Cherezov V., Melcher K.,
RA   Xu H.E.;
RT   "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray
RT   laser.";
RL   Nature 523:561-567(2015).
RN   [9] {ECO:0000244|PDB:5W0P}
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) IN COMPLEX WITH SAG, FUNCTION,
RP   TOPOLOGY, GLYCOSYLATION AT ASN-15, PHOSPHORYLATION AT SER-334; THR-336
RP   AND SER-338, DISULFIDE BOND, AND MUTAGENESIS OF 336-THR--THR-340;
RP   336-THR--SER-338 AND SER-343.
RX   PubMed=28753425; DOI=10.1016/j.cell.2017.07.002;
RA   Zhou X.E., He Y., de Waal P.W., Gao X., Kang Y., Van Eps N., Yin Y.,
RA   Pal K., Goswami D., White T.A., Barty A., Latorraca N.R.,
RA   Chapman H.N., Hubbell W.L., Dror R.O., Stevens R.C., Cherezov V.,
RA   Gurevich V.V., Griffin P.R., Ernst O.P., Melcher K., Xu H.E.;
RT   "Identification of Phosphorylation Codes for Arrestin Recruitment by G
RT   Protein-Coupled Receptors.";
RL   Cell 170:457-469(2017).
RN   [10]
RP   REVIEW ON RP4 VARIANTS.
RX   PubMed=8401533; DOI=10.1002/humu.1380020403;
RA   Al-Maghtheh M., Gregory C., Inglehearn C., Hardcastle A.,
RA   Bhattacharya S.;
RT   "Rhodopsin mutations in autosomal dominant retinitis pigmentosa.";
RL   Hum. Mutat. 2:249-255(1993).
RN   [11]
RP   VARIANTS RP4.
RX   PubMed=2239971;
RA   Farrar G.J., Kenna P., Redmond R., McWilliam P., Bradley D.G.,
RA   Humphries M.M., Sharp E.M., Inglehearn C.F., Bashir R., Jay M.,
RA   Watty A., Ludwig M., Schinzel A., Samanns C., Gal A.,
RA   Bhattacharya S.S., Humphries P.;
RT   "Autosomal dominant retinitis pigmentosa: absence of the rhodopsin
RT   proline-->histidine substitution (codon 23) in pedigrees from
RT   Europe.";
RL   Am. J. Hum. Genet. 47:941-945(1990).
RN   [12]
RP   VARIANT RP4 HIS-23.
RX   PubMed=2137202; DOI=10.1038/343364a0;
RA   Dryja T.P., McGee T.L., Reichei E., Hahn L.B., Cowley G.S.,
RA   Yandell D.W., Sandberg M.A., Berson E.L.;
RT   "A point mutation of the rhodopsin gene in one form of retinitis
RT   pigmentosa.";
RL   Nature 343:364-366(1990).
RN   [13]
RP   VARIANTS RP4 HIS-23; ARG-58; LEU-347 AND SER-347, AND FUNCTION.
RX   PubMed=2215617; DOI=10.1056/NEJM199011083231903;
RA   Dryja T.P., McGee T.L., Hahn L.B., Cowley G.S., Olsson J.E.,
RA   Reichel E., Sandberg M.A., Berson E.L.;
RT   "Mutations within the rhodopsin gene in patients with autosomal
RT   dominant retinitis pigmentosa.";
RL   N. Engl. J. Med. 323:1302-1307(1990).
RN   [14]
RP   VARIANT RP4 ILE-255 DEL.
RX   PubMed=1985460;
RA   Inglehearn C.F., Bashir R., Lester D.H., Jay M., Bird A.C.,
RA   Bhattacharya S.S.;
RT   "A 3-bp deletion in the rhodopsin gene in a family with autosomal
RT   dominant retinitis pigmentosa.";
RL   Am. J. Hum. Genet. 48:26-30(1991).
RN   [15]
RP   VARIANTS RP4 MET-17; HIS-23; ARG-58; SER-182 AND LEU-267.
RX   PubMed=1897520;
RA   Sheffield V.C., Fishman G.A., Beck J.S., Kimura A.E., Stone E.M.;
RT   "Identification of novel rhodopsin mutations associated with retinitis
RT   pigmentosa by GC-clamped denaturing gradient gel electrophoresis.";
RL   Am. J. Hum. Genet. 49:699-706(1991).
RN   [16]
RP   VARIANT RP4 ARG-347.
RX   PubMed=1840561;
RA   Gal A., Artlich A., Ludwig M., Niemeyer G., Olek K., Schwinger E.,
RA   Schinzel A.;
RT   "Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant
RT   retinitis pigmentosa.";
RL   Genomics 11:468-470(1991).
RN   [17]
RP   VARIANTS RP4.
RX   PubMed=1862076; DOI=10.1073/pnas.88.15.6481;
RA   Sung C.H., Davenport C.M., Hennessey J.C., Maumenee I.H.,
RA   Jacobson S.G., Heckenlively J.R., Nowakowski R., Fishman G.,
RA   Gouras P., Nathans J.;
RT   "Rhodopsin mutations in autosomal dominant retinitis pigmentosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6481-6485(1991).
RN   [18]
RP   VARIANTS RP4.
RX   PubMed=1833777; DOI=10.1073/pnas.88.20.9370;
RA   Dryja T.P., Hahn L.B., Cowley G.S., McGee T.L., Berson E.L.;
RT   "Mutation spectrum of the rhodopsin gene among patients with autosomal
RT   dominant retinitis pigmentosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9370-9374(1991).
RN   [19]
RP   VARIANT RP4 ARG-207.
RX   PubMed=1302614; DOI=10.1093/hmg/1.9.769;
RA   Farrar G.J., Findlay J.B.C., Kumar-Singh R., Kenna P., Humphries M.M.,
RA   Sharpe E., Humphries P.;
RT   "Autosomal dominant retinitis pigmentosa: a novel mutation in the
RT   rhodopsin gene in the original 3q linked family.";
RL   Hum. Mol. Genet. 1:769-771(1992).
RN   [20]
RP   VARIANTS RP4 MET-17 AND LEU-347.
RX   PubMed=1391967; DOI=10.1007/BF01899733;
RA   Fujiki K., Hotta Y., Hayakawa M., Sakuma H., Shiono T., Noro M.,
RA   Sakuma T., Tamai M., Hikiji K., Kawaguchi R., Hoshi A., Nakajima A.,
RA   Kanai A.;
RT   "Point mutations of rhodopsin gene found in Japanese families with
RT   autosomal dominant retinitis pigmentosa (ADRP).";
RL   Jpn. J. Hum. Genet. 37:125-132(1992).
RN   [21]
RP   VARIANTS RP4 ARG-106; GLY-135; SER-140; GLU-188 AND ARG-211, AND
RP   VARIANTS ALA-51; ILE-104 AND MET-209.
RX   PubMed=8317502;
RA   Macke J.P., Davenport C.M., Jacobson S.G., Hennessey J.C.,
RA   Gonzalez-Fernandez F., Conway B.P., Heckenlively J., Palmer R.,
RA   Maumenee I.H., Sieving P., Gouras P., Good W., Nathans J.;
RT   "Identification of novel rhodopsin mutations responsible for retinitis
RT   pigmentosa: implications for the structure and function of
RT   rhodopsin.";
RL   Am. J. Hum. Genet. 53:80-89(1993).
RN   [22]
RP   VARIANT RP4 SER-15.
RX   PubMed=8353500; DOI=10.1093/hmg/2.6.813;
RA   Kranich H., Bartkowski S., Denton M.J., Krey S., Dickinson P.,
RA   Duvigneau C., Gal A.;
RT   "Autosomal dominant 'sector' retinitis pigmentosa due to a point
RT   mutation predicting an Asn-15-Ser substitution of rhodopsin.";
RL   Hum. Mol. Genet. 2:813-814(1993).
RN   [23]
RP   VARIANT CSNBAD1 GLU-292.
RX   PubMed=8358437; DOI=10.1038/ng0793-280;
RA   Dryja T.P., Berson E.L., Rao V.R., Oprian D.D.;
RT   "Heterozygous missense mutation in the rhodopsin gene as a cause of
RT   congenital stationary night blindness.";
RL   Nat. Genet. 4:280-283(1993).
RN   [24]
RP   VARIANTS RP4.
RX   PubMed=8088850; DOI=10.1006/geno.1994.1301;
RA   Vaithinathan R., Berson E.L., Dryja T.P.;
RT   "Further screening of the rhodopsin gene in patients with autosomal
RT   dominant retinitis pigmentosa.";
RL   Genomics 21:461-463(1994).
RN   [25]
RP   VARIANT RP4 THR-44.
RX   PubMed=8076945; DOI=10.1007/BF00208284;
RA   Reig C., Antich J., Gean E., Garcia-Sandoval B., Ramos C., Ayuso C.,
RA   Carballo M.;
RT   "Identification of a novel rhodopsin mutation (Met-44-Thr) in a
RT   simplex case of retinitis pigmentosa.";
RL   Hum. Genet. 94:283-286(1994).
RN   [26]
RP   VARIANTS RP4 PHE-110; PRO-131 AND VAL-164.
RX   PubMed=7981701; DOI=10.1093/hmg/3.7.1203;
RA   Fuchs S., Kranich H., Denton M.J., Zrenner E., Bhattacharya S.S.,
RA   Humphries P., Gal A.;
RT   "Three novel rhodopsin mutations (C110F, L131P, A164V) in patients
RT   with autosomal dominant retinitis pigmentosa.";
RL   Hum. Mol. Genet. 3:1203-1203(1994).
RN   [27]
RP   VARIANT RP4 GLN-171.
RX   PubMed=7987326; DOI=10.1093/hmg/3.8.1421;
RA   Antinolo G., Sanchez B., Borrego S., Rueda T., Chaparro P.,
RA   Cabeza J.C.;
RT   "Identification of a new mutation at codon 171 of rhodopsin gene
RT   causing autosomal dominant retinitis pigmentosa.";
RL   Hum. Mol. Genet. 3:1421-1421(1994).
RN   [28]
RP   VARIANTS RP4 PHE-127; PRO-131; ASN-178; ARG-267 AND ARG-297.
RX   PubMed=7987331; DOI=10.1093/hmg/3.8.1433;
RA   Souied E., Gerber S., Rozet J.-M., Bonneau D., Dufier J.-L., Ghazi I.,
RA   Philip N., Soubrane G., Coscas G., Munnich A.;
RT   "Five novel missense mutations of the rhodopsin gene in autosomal
RT   dominant retinitis pigmentosa.";
RL   Hum. Mol. Genet. 3:1433-1434(1994).
RN   [29]
RP   VARIANTS RP4 ARG-40 AND LYS-216.
RX   PubMed=8081400; DOI=10.1002/humu.1380030417;
RA   Al-Maghtheh M., Inglehearn C., Lunt P., Jay M., Bird A.,
RA   Bhattacharya S.;
RT   "Two new rhodopsin transversion mutations (L40R; M216K) in families
RT   with autosomal dominant retinitis pigmentosa.";
RL   Hum. Mutat. 3:409-410(1994).
RN   [30]
RP   VARIANT RP4 LEU-345.
RX   PubMed=8045708;
RA   Rosas D.J., Roman A.J., Weissbrod P., Macke J.P., Nathans J.;
RT   "Autosomal dominant retinitis pigmentosa in a large family: a clinical
RT   and molecular genetic study.";
RL   Invest. Ophthalmol. Vis. Sci. 35:3134-3144(1994).
RN   [31]
RP   CHARACTERIZATION OF VARIANT CSNBAD1 ASP-90, AND FUNCTION.
RX   PubMed=8107847; DOI=10.1038/367639a0;
RA   Rao V.R., Cohen G.B., Oprian D.D.;
RT   "Rhodopsin mutation G90D and a molecular mechanism for congenital
RT   night blindness.";
RL   Nature 367:639-642(1994).
RN   [32]
RP   VARIANT ARRP LYS-150.
RX   PubMed=7987385; DOI=10.1038/ng0994-10;
RA   Kumaramanickavel G., Maw M., Denton M.J., John S., Srikumari C.R.,
RA   Orth U., Oehlmann R., Gal A.;
RT   "Missense rhodopsin mutation in a family with recessive RP.";
RL   Nat. Genet. 8:10-11(1994).
RN   [33]
RP   VARIANT RP4 ALA-347.
RX   PubMed=7633434; DOI=10.1093/hmg/4.4.775;
RA   Macke J.P., Hennessey J.C., Nathans J.;
RT   "Rhodopsin mutation proline347-to-alanine in a family with autosomal
RT   dominant retinitis pigmentosa indicates an important role for proline
RT   at position 347.";
RL   Hum. Mol. Genet. 4:775-776(1995).
RN   [34]
RP   VARIANT CSNBAD1 ASP-90, AND FUNCTION.
RX   PubMed=7846071; DOI=10.1073/pnas.92.3.880;
RA   Sieving P.A., Richards J.E., Naarendorp F., Bingham E.L., Scott K.,
RA   Alpern M.;
RT   "Dark-light: model for nightblindness from the human rhodopsin Gly-
RT   90-->Asp mutation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:880-884(1995).
RN   [35]
RP   VARIANT RP4 TRP-135.
RX   PubMed=8554077; DOI=10.1016/S0002-9394(14)70530-6;
RA   Souied E., Soubrane G., Benlian P., Coscas G.J., Gerber S.,
RA   Munnich A., Kaplan J.;
RT   "Retinitis punctata albescens associated with the Arg135Trp mutation
RT   in the rhodopsin gene.";
RL   Am. J. Ophthalmol. 121:19-25(1996).
RN   [36]
RP   VARIANT RP4 ARG-109.
RX   PubMed=9452035;
RA   Goliath R., Bardien S., September A., Martin R., Ramesar R.,
RA   Greenberg J.;
RT   "Rhodopsin mutation G109R in a family with autosomal dominant
RT   retinitis pigmentosa.";
RL   Hum. Mutat. Suppl. 1:S40-S41(1998).
RN   [37]
RP   VARIANT CSNBAD1 ILE-94.
RX   PubMed=9888392;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO;2-4;
RA   Al-Jandal N., Farrar G.J., Kiang A.-S., Humphries M.M., Bannon N.,
RA   Findlay J.B.C., Humphries P., Kenna P.F.;
RT   "A novel mutation within the rhodopsin gene (Thr-94-Ile) causing
RT   autosomal dominant congenital stationary night blindness.";
RL   Hum. Mutat. 13:75-81(1999).
RN   [38]
RP   CHARACTERIZATION OF VARIANT RP4 HIS-23, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12566452; DOI=10.1074/jbc.M300087200;
RA   Noorwez S.M., Kuksa V., Imanishi Y., Zhu L., Filipek S.,
RA   Palczewski K., Kaushal S.;
RT   "Pharmacological chaperone-mediated in vivo folding and stabilization
RT   of the P23H-opsin mutant associated with autosomal dominant retinitis
RT   pigmentosa.";
RL   J. Biol. Chem. 278:14442-14450(2003).
RN   [39]
RP   CHARACTERIZATION OF VARIANT RP4 HIS-23, AND SUBCELLULAR LOCATION.
RX   PubMed=19934218; DOI=10.1242/jcs.055228;
RA   Kosmaoglou M., Kanuga N., Aguila M., Garriga P., Cheetham M.E.;
RT   "A dual role for EDEM1 in the processing of rod opsin.";
RL   J. Cell Sci. 122:4465-4472(2009).
RN   [40]
RP   VARIANT RP4 LYS-150.
RX   PubMed=19960070;
RA   Azam M., Khan M.I., Gal A., Hussain A., Shah S.T., Khan M.S.,
RA   Sadeque A., Bokhari H., Collin R.W., Orth U., van Genderen M.M.,
RA   den Hollander A.I., Cremers F.P., Qamar R.;
RT   "A homozygous p.Glu150Lys mutation in the opsin gene of two Pakistani
RT   families with autosomal recessive retinitis pigmentosa.";
RL   Mol. Vis. 15:2526-2534(2009).
RN   [41]
RP   VARIANTS RP4 TRP-135; SER-180 AND ASN-214.
RX   PubMed=22334370; DOI=10.1002/humu.22045;
RA   Neveling K., Collin R.W., Gilissen C., van Huet R.A., Visser L.,
RA   Kwint M.P., Gijsen S.J., Zonneveld M.N., Wieskamp N., de Ligt J.,
RA   Siemiatkowska A.M., Hoefsloot L.H., Buckley M.F., Kellner U.,
RA   Branham K.E., den Hollander A.I., Hoischen A., Hoyng C.,
RA   Klevering B.J., van den Born L.I., Veltman J.A., Cremers F.P.,
RA   Scheffer H.;
RT   "Next-generation genetic testing for retinitis pigmentosa.";
RL   Hum. Mutat. 33:963-972(2012).
RN   [42]
RP   VARIANT ILE-104.
RX   PubMed=28837730; DOI=10.1167/iovs.16-20941;
RA   Wang B., Liu Y., Chen S., Wu Y., Lin S., Duan Y., Zheng K., Zhang L.,
RA   Gu X., Hong W., Shao H., Zeng X., Sun B., Duan S.;
RT   "A novel potentially causative variant of NDUFAF7 revealed by mutation
RT   screening in a chinese family with pathologic myopia.";
RL   Invest. Ophthalmol. Vis. Sci. 58:4182-4192(2017).
CC   -!- FUNCTION: Photoreceptor required for image-forming vision at low
CC       light intensity (PubMed:8107847, PubMed:7846071). Required for
CC       photoreceptor cell viability after birth (PubMed:2215617,
CC       PubMed:12566452). Light-induced isomerization of the chromophore
CC       11-cis-retinal to all-trans-retinal triggers a conformational
CC       change that activates signaling via G-proteins (PubMed:8107847,
CC       PubMed:28524165, PubMed:26200343, PubMed:28753425). Subsequent
CC       receptor phosphorylation mediates displacement of the bound G-
CC       protein alpha subunit by the arrestin SAG and terminates signaling
CC       (PubMed:28524165, PubMed:26200343). {ECO:0000269|PubMed:12566452,
CC       ECO:0000269|PubMed:2215617, ECO:0000269|PubMed:26200343,
CC       ECO:0000269|PubMed:28753425, ECO:0000269|PubMed:7846071,
CC       ECO:0000269|PubMed:8107847, ECO:0000305|PubMed:28524165}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts (phosphorylated
CC       form) with SAG (PubMed:28524165, PubMed:26200343,
CC       PubMed:28753425). Interacts with GNAT1 (PubMed:26200343).
CC       Interacts with GNAT3. SAG and G-proteins compete for a common
CC       binding site (By similarity). Interacts with GRK1
CC       (PubMed:28524165). Interacts with PRCD; the interaction promotes
CC       PRCD stability (By similarity). {ECO:0000250|UniProtKB:P02699,
CC       ECO:0000250|UniProtKB:P15409, ECO:0000269|PubMed:26200343,
CC       ECO:0000269|PubMed:28524165, ECO:0000269|PubMed:28753425}.
CC   -!- INTERACTION:
CC       O95405:ZFYVE9; NbExp=2; IntAct=EBI-1394177, EBI-296817;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:12566452,
CC       ECO:0000269|PubMed:19934218, ECO:0000269|PubMed:25664179,
CC       ECO:0000269|PubMed:26200343, ECO:0000269|PubMed:28753425}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:19934218,
CC       ECO:0000269|PubMed:26200343, ECO:0000269|PubMed:28753425}. Cell
CC       projection, cilium, photoreceptor outer segment
CC       {ECO:0000269|PubMed:25664179}. Note=Synthesized in the inner
CC       segment (IS) of rod photoreceptor cells before vectorial transport
CC       to disk membranes in the rod outer segment (OS) photosensory
CC       cilia. {ECO:0000269|PubMed:25664179}.
CC   -!- TISSUE SPECIFICITY: Rod shaped photoreceptor cells which mediate
CC       vision in dim light.
CC   -!- PTM: Phosphorylated on some or all of the serine and threonine
CC       residues present in the C-terminal region (By similarity). After
CC       activation by light, phosphorylated by GRK1 (in vitro)
CC       (PubMed:28524165). {ECO:0000250|UniProtKB:P02699,
CC       ECO:0000269|PubMed:28524165}.
CC   -!- PTM: Contains one covalently linked retinal chromophore. Upon
CC       light absorption, the covalently bound 11-cis-retinal is converted
CC       to all-trans-retinal. After hydrolysis of the Schiff base and
CC       release of the covalently bound all-trans-retinal, active
CC       rhodopsin is regenerated by binding of a fresh molecule of 11-cis-
CC       retinal(PubMed:12566452). {ECO:0000269|PubMed:12566452}.
CC   -!- DISEASE: Retinitis pigmentosa 4 (RP4) [MIM:613731]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:12566452,
CC       ECO:0000269|PubMed:1302614, ECO:0000269|PubMed:1391967,
CC       ECO:0000269|PubMed:1833777, ECO:0000269|PubMed:1840561,
CC       ECO:0000269|PubMed:1862076, ECO:0000269|PubMed:1897520,
CC       ECO:0000269|PubMed:1985460, ECO:0000269|PubMed:19934218,
CC       ECO:0000269|PubMed:19960070, ECO:0000269|PubMed:2137202,
CC       ECO:0000269|PubMed:2215617, ECO:0000269|PubMed:22334370,
CC       ECO:0000269|PubMed:2239971, ECO:0000269|PubMed:7633434,
CC       ECO:0000269|PubMed:7981701, ECO:0000269|PubMed:7987326,
CC       ECO:0000269|PubMed:7987331, ECO:0000269|PubMed:8045708,
CC       ECO:0000269|PubMed:8076945, ECO:0000269|PubMed:8081400,
CC       ECO:0000269|PubMed:8088850, ECO:0000269|PubMed:8317502,
CC       ECO:0000269|PubMed:8353500, ECO:0000269|PubMed:8554077,
CC       ECO:0000269|PubMed:9452035}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Night blindness, congenital stationary, autosomal
CC       dominant 1 (CSNBAD1) [MIM:610445]: A non-progressive retinal
CC       disorder characterized by impaired night vision, often associated
CC       with nystagmus and myopia. {ECO:0000269|PubMed:7846071,
CC       ECO:0000269|PubMed:8107847, ECO:0000269|PubMed:8358437,
CC       ECO:0000269|PubMed:9888392}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Opsin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Mutations of the RHO gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/rhomut.htm";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Rhodopsin entry;
CC       URL="https://en.wikipedia.org/wiki/Rhodopsin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U49742; AAC31763.1; -; Genomic_DNA.
DR   EMBL; AB065668; BAC05894.1; -; Genomic_DNA.
DR   EMBL; BX537381; CAD97623.1; -; mRNA.
DR   EMBL; BC112104; AAI12105.1; -; mRNA.
DR   EMBL; BC112106; AAI12107.1; -; mRNA.
DR   EMBL; U16824; AAA97436.1; -; Genomic_DNA.
DR   EMBL; S81166; AAB35906.1; -; Genomic_DNA.
DR   CCDS; CCDS3063.1; -.
DR   PIR; A41200; OOHU.
DR   RefSeq; NP_000530.1; NM_000539.3.
DR   UniGene; Hs.247565; -.
DR   PDB; 4ZWJ; X-ray; 3.30 A; A/B/C/D=1-348.
DR   PDB; 5DGY; X-ray; 7.70 A; A/B/C/D=1-348.
DR   PDB; 5W0P; X-ray; 3.01 A; A/B/C/D=1-348.
DR   PDB; 6CMO; EM; 4.50 A; R=3-323.
DR   PDBsum; 4ZWJ; -.
DR   PDBsum; 5DGY; -.
DR   PDBsum; 5W0P; -.
DR   PDBsum; 6CMO; -.
DR   ProteinModelPortal; P08100; -.
DR   SMR; P08100; -.
DR   BioGrid; 111942; 11.
DR   IntAct; P08100; 4.
DR   STRING; 9606.ENSP00000296271; -.
DR   DrugBank; DB04233; (Hydroxyethyloxy)Tri(Ethyloxy)Octane.
DR   DrugBank; DB03152; B-2-Octylglucoside.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB04450; Heptyl 1-Thiohexopyranoside.
DR   DrugBank; DB03381; Hexadecanal.
DR   DrugBank; DB04147; Lauryl Dimethylamine-N-Oxide.
DR   DrugBank; DB01646; N-Acetylmethionine.
DR   DrugBank; DB03796; Palmitic Acid.
DR   DrugBank; DB04522; Phosphonoserine.
DR   DrugBank; DB02482; Phosphonothreonine.
DR   TCDB; 9.A.14.1.2; the g-protein-coupled receptor (gpcr) family.
DR   GlyConnect; 525; -.
DR   iPTMnet; P08100; -.
DR   PhosphoSitePlus; P08100; -.
DR   SwissPalm; P08100; -.
DR   UniCarbKB; P08100; -.
DR   BioMuta; RHO; -.
DR   DMDM; 129207; -.
DR   PaxDb; P08100; -.
DR   PeptideAtlas; P08100; -.
DR   PRIDE; P08100; -.
DR   ProteomicsDB; 52066; -.
DR   DNASU; 6010; -.
DR   Ensembl; ENST00000296271; ENSP00000296271; ENSG00000163914.
DR   GeneID; 6010; -.
DR   KEGG; hsa:6010; -.
DR   UCSC; uc003emt.4; human.
DR   CTD; 6010; -.
DR   DisGeNET; 6010; -.
DR   EuPathDB; HostDB:ENSG00000163914.4; -.
DR   GeneCards; RHO; -.
DR   GeneReviews; RHO; -.
DR   HGNC; HGNC:10012; RHO.
DR   HPA; CAB022486; -.
DR   HPA; CAB034887; -.
DR   HPA; CAB034888; -.
DR   HPA; HPA013440; -.
DR   MalaCards; RHO; -.
DR   MIM; 180380; gene.
DR   MIM; 610445; phenotype.
DR   MIM; 613731; phenotype.
DR   neXtProt; NX_P08100; -.
DR   OpenTargets; ENSG00000163914; -.
DR   Orphanet; 215; Congenital stationary night blindness.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   Orphanet; 52427; Retinitis punctata albescens.
DR   PharmGKB; PA34390; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   GeneTree; ENSGT00940000154379; -.
DR   HOGENOM; HOG000253932; -.
DR   HOVERGEN; HBG107442; -.
DR   InParanoid; P08100; -.
DR   KO; K04250; -.
DR   OMA; LAAYMFM; -.
DR   OrthoDB; 541116at2759; -.
DR   PhylomeDB; P08100; -.
DR   TreeFam; TF324998; -.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   Reactome; R-HSA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-419771; Opsins.
DR   Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium.
DR   SignaLink; P08100; -.
DR   SIGNOR; P08100; -.
DR   ChiTaRS; RHO; human.
DR   GeneWiki; Rhodopsin; -.
DR   GenomeRNAi; 6010; -.
DR   PRO; PR:P08100; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163914; Expressed in 87 organ(s), highest expression level in retina.
DR   Genevisible; P08100; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:MGI.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0097381; C:photoreceptor disc membrane; IDA:UniProtKB.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:MGI.
DR   GO; GO:0060342; C:photoreceptor inner segment membrane; IDA:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; IDA:MGI.
DR   GO; GO:0042622; C:photoreceptor outer segment membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:LIFEdb.
DR   GO; GO:0005502; F:11-cis retinal binding; ISS:UniProtKB.
DR   GO; GO:0008020; F:G protein-coupled photoreceptor activity; ISS:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016038; P:absorption of visible light; ISS:AgBase.
DR   GO; GO:0071482; P:cellular response to light stimulus; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl.
DR   GO; GO:0007602; P:phototransduction; IBA:GO_Central.
DR   GO; GO:0007603; P:phototransduction, visible light; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001760; Opsin.
DR   InterPro; IPR027430; Retinal_BS.
DR   InterPro; IPR000732; Rhodopsin.
DR   InterPro; IPR019477; Rhodopsin_N.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF10413; Rhodopsin_N; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00238; OPSIN.
DR   PRINTS; PR00579; RHODOPSIN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
DR   PROSITE; PS00238; OPSIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell projection; Chromophore;
KW   Complete proteome; Congenital stationary night blindness;
KW   Disease mutation; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Metal-binding; Palmitate;
KW   Phosphoprotein; Photoreceptor protein; Polymorphism; Receptor;
KW   Reference proteome; Retinal protein; Retinitis pigmentosa;
KW   Sensory transduction; Transducer; Transmembrane; Transmembrane helix;
KW   Vision; Zinc.
FT   CHAIN         1    348       Rhodopsin.
FT                                /FTId=PRO_0000197677.
FT   TOPO_DOM      1     36       Extracellular.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM     37     61       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM     62     73       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM     74     96       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM     97    110       Extracellular.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM    111    133       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM    134    152       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM    153    173       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM    174    202       Extracellular.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM    203    224       Helical; Name=5.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM    225    252       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM    253    274       Helical; Name=6.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM    275    284       Extracellular.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TRANSMEM    285    309       Helical; Name=7.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   TOPO_DOM    310    348       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   REGION      330    348       Interaction with SAG.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   MOTIF       134    136       'Ionic lock' involved in activated form
FT                                stabilization.
FT                                {ECO:0000305|PubMed:26200343}.
FT   METAL       201    201       Zinc. {ECO:0000250|UniProtKB:P02699}.
FT   METAL       279    279       Zinc. {ECO:0000250|UniProtKB:P02699}.
FT   SITE        113    113       Plays an important role in the
FT                                conformation switch to the active
FT                                conformation.
FT                                {ECO:0000269|PubMed:26200343}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   MOD_RES     296    296       N6-(retinylidene)lysine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   MOD_RES     334    334       Phosphoserine.
FT                                {ECO:0000269|PubMed:28753425}.
FT   MOD_RES     336    336       Phosphothreonine.
FT                                {ECO:0000269|PubMed:28753425}.
FT   MOD_RES     338    338       Phosphoserine.
FT                                {ECO:0000269|PubMed:28753425}.
FT   MOD_RES     340    340       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   MOD_RES     342    342       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   LIPID       322    322       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   LIPID       323    323       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   CARBOHYD      2      2       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250|UniProtKB:P02699}.
FT   CARBOHYD     15     15       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:28753425}.
FT   DISULFID    110    187       {ECO:0000255|PROSITE-ProRule:PRU00521,
FT                                ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28753425}.
FT   VARIANT       4      4       T -> K (in RP4).
FT                                /FTId=VAR_004765.
FT   VARIANT      15     15       N -> S (in RP4; dbSNP:rs104893786).
FT                                {ECO:0000269|PubMed:8353500}.
FT                                /FTId=VAR_004766.
FT   VARIANT      17     17       T -> M (in RP4; dbSNP:rs104893769).
FT                                {ECO:0000269|PubMed:1391967,
FT                                ECO:0000269|PubMed:1897520}.
FT                                /FTId=VAR_004767.
FT   VARIANT      23     23       P -> H (in RP4; most common variant;
FT                                impairs protein folding; leads to
FT                                interaction with EDEM1 followed by
FT                                degradation by the ERAD system;
FT                                dbSNP:rs104893768).
FT                                {ECO:0000269|PubMed:12566452,
FT                                ECO:0000269|PubMed:1897520,
FT                                ECO:0000269|PubMed:19934218,
FT                                ECO:0000269|PubMed:2137202,
FT                                ECO:0000269|PubMed:2215617}.
FT                                /FTId=VAR_004768.
FT   VARIANT      23     23       P -> L (in RP4).
FT                                /FTId=VAR_004769.
FT   VARIANT      28     28       Q -> H (in RP4).
FT                                /FTId=VAR_004770.
FT   VARIANT      40     40       L -> R (in RP4).
FT                                {ECO:0000269|PubMed:8081400}.
FT                                /FTId=VAR_004771.
FT   VARIANT      44     44       M -> T (in RP4; dbSNP:rs774336493).
FT                                {ECO:0000269|PubMed:8076945}.
FT                                /FTId=VAR_004772.
FT   VARIANT      45     45       F -> L (in RP4; dbSNP:rs104893770).
FT                                /FTId=VAR_004773.
FT   VARIANT      46     46       L -> R (in RP4).
FT                                /FTId=VAR_004774.
FT   VARIANT      51     51       G -> A (in dbSNP:rs149079952).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004775.
FT   VARIANT      51     51       G -> R (in RP4; dbSNP:rs104893792).
FT                                /FTId=VAR_004776.
FT   VARIANT      51     51       G -> V (in RP4).
FT                                /FTId=VAR_004777.
FT   VARIANT      53     53       P -> R (in RP4; dbSNP:rs28933395).
FT                                /FTId=VAR_004778.
FT   VARIANT      58     58       T -> R (in RP4; dbSNP:rs28933394).
FT                                {ECO:0000269|PubMed:1897520,
FT                                ECO:0000269|PubMed:2215617}.
FT                                /FTId=VAR_004779.
FT   VARIANT      68     71       Missing (in RP4).
FT                                /FTId=VAR_004780.
FT   VARIANT      87     87       V -> D (in RP4; dbSNP:rs104893771).
FT                                /FTId=VAR_004781.
FT   VARIANT      89     89       G -> D (in RP4; dbSNP:rs104893772).
FT                                /FTId=VAR_004782.
FT   VARIANT      90     90       G -> D (in CSNBAD1; constitutive activity
FT                                in the absence of bound retinal;
FT                                dbSNP:rs104893790).
FT                                {ECO:0000269|PubMed:7846071,
FT                                ECO:0000269|PubMed:8107847}.
FT                                /FTId=VAR_004783.
FT   VARIANT      94     94       T -> I (in CSNBAD1; dbSNP:rs104893796).
FT                                {ECO:0000269|PubMed:9888392}.
FT                                /FTId=VAR_004784.
FT   VARIANT     104    104       V -> I (found in patients with pathologic
FT                                myopia; unknown pathological
FT                                significance; dbSNP:rs144317206).
FT                                {ECO:0000269|PubMed:28837730,
FT                                ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004785.
FT   VARIANT     106    106       G -> R (in RP4; dbSNP:rs104893773).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004786.
FT   VARIANT     106    106       G -> W (in RP4; dbSNP:rs104893773).
FT                                /FTId=VAR_004787.
FT   VARIANT     109    109       G -> R (in RP4; dbSNP:rs1415160298).
FT                                {ECO:0000269|PubMed:9452035}.
FT                                /FTId=VAR_004788.
FT   VARIANT     110    110       C -> F (in RP4).
FT                                {ECO:0000269|PubMed:7981701}.
FT                                /FTId=VAR_004789.
FT   VARIANT     110    110       C -> Y (in RP4; dbSNP:rs104893787).
FT                                /FTId=VAR_004790.
FT   VARIANT     114    114       G -> D (in RP4; dbSNP:rs104893788).
FT                                /FTId=VAR_004791.
FT   VARIANT     125    125       L -> R (in RP4).
FT                                /FTId=VAR_004792.
FT   VARIANT     127    127       S -> F (in RP4).
FT                                {ECO:0000269|PubMed:7987331}.
FT                                /FTId=VAR_004793.
FT   VARIANT     131    131       L -> P (in RP4).
FT                                {ECO:0000269|PubMed:7981701,
FT                                ECO:0000269|PubMed:7987331}.
FT                                /FTId=VAR_004794.
FT   VARIANT     135    135       R -> G (in RP4).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004795.
FT   VARIANT     135    135       R -> L (in RP4; dbSNP:rs104893774).
FT                                /FTId=VAR_004796.
FT   VARIANT     135    135       R -> W (in RP4; dbSNP:rs104893775).
FT                                {ECO:0000269|PubMed:22334370,
FT                                ECO:0000269|PubMed:8554077}.
FT                                /FTId=VAR_004797.
FT   VARIANT     140    140       C -> S (in RP4).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004798.
FT   VARIANT     150    150       E -> K (in RP4; autosomal recessive;
FT                                dbSNP:rs104893791).
FT                                {ECO:0000269|PubMed:19960070,
FT                                ECO:0000269|PubMed:7987385}.
FT                                /FTId=VAR_004799.
FT   VARIANT     164    164       A -> E (in RP4; dbSNP:rs104893793).
FT                                /FTId=VAR_004800.
FT   VARIANT     164    164       A -> V (in RP4; dbSNP:rs104893793).
FT                                {ECO:0000269|PubMed:7981701}.
FT                                /FTId=VAR_004801.
FT   VARIANT     167    167       C -> R (in RP4).
FT                                /FTId=VAR_004802.
FT   VARIANT     171    171       P -> L (in RP4).
FT                                /FTId=VAR_004803.
FT   VARIANT     171    171       P -> Q (in RP4).
FT                                {ECO:0000269|PubMed:7987326}.
FT                                /FTId=VAR_004804.
FT   VARIANT     171    171       P -> S (in RP4; dbSNP:rs104893794).
FT                                /FTId=VAR_004805.
FT   VARIANT     178    178       Y -> C (in RP4; dbSNP:rs104893776).
FT                                /FTId=VAR_004806.
FT   VARIANT     178    178       Y -> N (in RP4).
FT                                {ECO:0000269|PubMed:7987331}.
FT                                /FTId=VAR_004807.
FT   VARIANT     180    180       P -> S (in RP4).
FT                                {ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_068359.
FT   VARIANT     181    181       E -> K (in RP4; dbSNP:rs775557680).
FT                                /FTId=VAR_004808.
FT   VARIANT     182    182       G -> S (in RP4; dbSNP:rs104893780).
FT                                {ECO:0000269|PubMed:1897520}.
FT                                /FTId=VAR_004809.
FT   VARIANT     186    186       S -> P (in RP4).
FT                                /FTId=VAR_004810.
FT   VARIANT     188    188       G -> E (in RP4; dbSNP:rs1424131846).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004811.
FT   VARIANT     188    188       G -> R (in RP4; dbSNP:rs527236100).
FT                                /FTId=VAR_004812.
FT   VARIANT     190    190       D -> G (in RP4; dbSNP:rs104893777).
FT                                /FTId=VAR_004814.
FT   VARIANT     190    190       D -> N (in RP4; dbSNP:rs104893779).
FT                                /FTId=VAR_004813.
FT   VARIANT     190    190       D -> Y (in RP4; dbSNP:rs104893779).
FT                                /FTId=VAR_004815.
FT   VARIANT     207    207       M -> R (in RP4; dbSNP:rs104893782).
FT                                {ECO:0000269|PubMed:1302614}.
FT                                /FTId=VAR_004816.
FT   VARIANT     209    209       V -> M (found in a patient with retinitis
FT                                pigmentosa; unknown pathological
FT                                significance; dbSNP:rs567288669).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004817.
FT   VARIANT     211    211       H -> P (in RP4; dbSNP:rs28933993).
FT                                /FTId=VAR_004818.
FT   VARIANT     211    211       H -> R (in RP4).
FT                                {ECO:0000269|PubMed:8317502}.
FT                                /FTId=VAR_004819.
FT   VARIANT     214    214       I -> N (in RP4).
FT                                {ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_068360.
FT   VARIANT     216    216       M -> K (in RP4).
FT                                {ECO:0000269|PubMed:8081400}.
FT                                /FTId=VAR_004820.
FT   VARIANT     220    220       F -> C (in RP4; dbSNP:rs766161322).
FT                                /FTId=VAR_004821.
FT   VARIANT     222    222       C -> R (in RP4).
FT                                /FTId=VAR_004822.
FT   VARIANT     255    255       Missing (in RP4).
FT                                {ECO:0000269|PubMed:1985460}.
FT                                /FTId=VAR_004823.
FT   VARIANT     264    264       Missing (in RP4).
FT                                /FTId=VAR_004824.
FT   VARIANT     267    267       P -> L (in RP4; dbSNP:rs104893781).
FT                                {ECO:0000269|PubMed:1897520}.
FT                                /FTId=VAR_004825.
FT   VARIANT     267    267       P -> R (in RP4).
FT                                {ECO:0000269|PubMed:7987331}.
FT                                /FTId=VAR_004826.
FT   VARIANT     292    292       A -> E (in CSNBAD1; dbSNP:rs104893789).
FT                                {ECO:0000269|PubMed:8358437}.
FT                                /FTId=VAR_004827.
FT   VARIANT     296    296       K -> E (in RP4; dbSNP:rs29001653).
FT                                /FTId=VAR_004828.
FT   VARIANT     297    297       S -> R (in RP4).
FT                                {ECO:0000269|PubMed:7987331}.
FT                                /FTId=VAR_004829.
FT   VARIANT     342    342       T -> M (in RP4; dbSNP:rs183318466).
FT                                /FTId=VAR_004830.
FT   VARIANT     345    345       V -> L (in RP4; dbSNP:rs104893795).
FT                                {ECO:0000269|PubMed:8045708}.
FT                                /FTId=VAR_004831.
FT   VARIANT     345    345       V -> M (in RP4; dbSNP:rs104893795).
FT                                /FTId=VAR_004832.
FT   VARIANT     347    347       P -> A (in RP4).
FT                                {ECO:0000269|PubMed:7633434}.
FT                                /FTId=VAR_004833.
FT   VARIANT     347    347       P -> L (in RP4; common variant;
FT                                dbSNP:rs29001566).
FT                                {ECO:0000269|PubMed:1391967,
FT                                ECO:0000269|PubMed:2215617}.
FT                                /FTId=VAR_004834.
FT   VARIANT     347    347       P -> Q (in RP4; dbSNP:rs29001566).
FT                                /FTId=VAR_004835.
FT   VARIANT     347    347       P -> R (in RP4; dbSNP:rs29001566).
FT                                {ECO:0000269|PubMed:1840561}.
FT                                /FTId=VAR_004836.
FT   VARIANT     347    347       P -> S (in RP4; dbSNP:rs29001637).
FT                                {ECO:0000269|PubMed:2215617}.
FT                                /FTId=VAR_004837.
FT   MUTAGEN     113    113       E->Q: Induces a conformation change that
FT                                promotes interaction with GRK1 and SAG;
FT                                when associated with Y-257.
FT                                {ECO:0000269|PubMed:26200343}.
FT   MUTAGEN     257    257       M->Y: Induces a conformation change that
FT                                promotes interaction with GRK1 and SAG;
FT                                when associated with Q-113.
FT                                {ECO:0000269|PubMed:26200343,
FT                                ECO:0000269|PubMed:28524165}.
FT   MUTAGEN     336    340       TVSKT->AVAKA: Loss of phosphorylation
FT                                sites and decreased interaction with SAG.
FT                                {ECO:0000269|PubMed:28753425}.
FT   MUTAGEN     336    338       TVS->AVA: Loss of phosphorylation sites
FT                                and decreased interaction with SAG; when
FT                                associated with A-343.
FT                                {ECO:0000269|PubMed:28753425}.
FT   MUTAGEN     343    343       S->A: Loss of phosphorylation sites and
FT                                decreased interaction with SAG; when
FT                                associated with 336-A--A-338.
FT                                {ECO:0000269|PubMed:28753425}.
FT   STRAND        2      5       {ECO:0000244|PDB:5W0P}.
FT   STRAND       10     13       {ECO:0000244|PDB:5W0P}.
FT   STRAND       16     18       {ECO:0000244|PDB:5W0P}.
FT   TURN         23     25       {ECO:0000244|PDB:5W0P}.
FT   TURN         29     31       {ECO:0000244|PDB:4ZWJ}.
FT   HELIX        35     64       {ECO:0000244|PDB:5W0P}.
FT   HELIX        66     68       {ECO:0000244|PDB:5W0P}.
FT   TURN         71     73       {ECO:0000244|PDB:5W0P}.
FT   HELIX        74     88       {ECO:0000244|PDB:5W0P}.
FT   HELIX        90    100       {ECO:0000244|PDB:5W0P}.
FT   HELIX       106    140       {ECO:0000244|PDB:5W0P}.
FT   HELIX       143    147       {ECO:0000244|PDB:5W0P}.
FT   HELIX       150    168       {ECO:0000244|PDB:5W0P}.
FT   HELIX       170    173       {ECO:0000244|PDB:5W0P}.
FT   STRAND      174    176       {ECO:0000244|PDB:4ZWJ}.
FT   STRAND      178    181       {ECO:0000244|PDB:5W0P}.
FT   TURN        182    185       {ECO:0000244|PDB:5W0P}.
FT   STRAND      186    189       {ECO:0000244|PDB:5W0P}.
FT   STRAND      191    193       {ECO:0000244|PDB:5W0P}.
FT   TURN        196    199       {ECO:0000244|PDB:5W0P}.
FT   HELIX       200    209       {ECO:0000244|PDB:5W0P}.
FT   TURN        210    212       {ECO:0000244|PDB:5W0P}.
FT   HELIX       213    236       {ECO:0000244|PDB:5W0P}.
FT   HELIX       241    277       {ECO:0000244|PDB:5W0P}.
FT   HELIX       285    306       {ECO:0000244|PDB:5W0P}.
FT   TURN        307    309       {ECO:0000244|PDB:5W0P}.
FT   HELIX       311    321       {ECO:0000244|PDB:5W0P}.
FT   TURN        322    324       {ECO:0000244|PDB:4ZWJ}.
FT   TURN        331    333       {ECO:0000244|PDB:5W0P}.
FT   STRAND      339    341       {ECO:0000244|PDB:5W0P}.
SQ   SEQUENCE   348 AA;  38893 MW;  6F4F6FCBA34265B2 CRC64;
     MNGTEGPNFY VPFSNATGVV RSPFEYPQYY LAEPWQFSML AAYMFLLIVL GFPINFLTLY
     VTVQHKKLRT PLNYILLNLA VADLFMVLGG FTSTLYTSLH GYFVFGPTGC NLEGFFATLG
     GEIALWSLVV LAIERYVVVC KPMSNFRFGE NHAIMGVAFT WVMALACAAP PLAGWSRYIP
     EGLQCSCGID YYTLKPEVNN ESFVIYMFVV HFTIPMIIIF FCYGQLVFTV KEAAAQQQES
     ATTQKAEKEV TRMVIIMVIA FLICWVPYAS VAFYIFTHQG SNFGPIFMTI PAFFAKSAAI
     YNPVIYIMMN KQFRNCMLTT ICCGKNPLGD DEASATVSKT ETSQVAPA
//
